Phage therapy: Regulatory perspectives from TATFAR
Dear All, Integrating perspectives from EC HERA, EMA, Health Canada, Norway, UK MHRA, US FDA, and US NIH, the Transatlantic Task Force on AMR (TATFAR)’s Phage Working Group have just published a detailed summary of information on phage therapy with particular focus on its regulatory aspects. Here are the links you need: [key paper for this